Minor
REScUE-OLE · Monitoring Study · Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study
Trial completed
Also in this update: Final enrollment: 41 participants (planned 108)
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZWPhase 3 NCT05299931 Registry history of NCT05299931 on ClinicalTrials.gov (opens the registry)